Aarvik Therapeutics, an innovative, ADC-focused biotechnology company dedicated to engineering precision medicines for cancer therapy, is pleased to announce that it will present two posters and a ...

Too frequently, clinicians think all they need to say is, ‘I know better,’ and that’s not what patients need to hear,” said Christy J.W. Ledford, PhD, communication scientist at the Medical College of ...

Join our webinar on World TB Day to explore patient-centric care, challenges, and technological advancements in tuberculosis treatment.

Digital communication provides additional channels for patients to stay connected with medical providers between ...

CyPath® Lung improves diagnostic clarity in patients with multiple lung nodules. In this case study, CyPath® Lung “Unlikely Malignancy” result supported physician’s decisi ...

M.V. Ramana, CEO of Branded Markets at Dr. Reddy's, believes four pillars will define the leaders: fully integrated ...

International medical technology and cybersecurity company Sectra(STO: SECT B) has signed a three-year agreement to provide its cloud-based Sectra Education Portal to all Norwegian health regions. The ...

Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such ...

ACR-368, a CHK1/2 inhibitor in a registrational-intent Phase 2b study, showed potent preclinical synergy with Topoisomerase 1 (Topo 1) ...

As the global burden of obesity, type 2 diabetes, and metabolic syndrome continues to rise, fatty liver disease has become one of the most prevalent chronic liver conditions worldwide. Its progressive ...